Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Therapeutic Drug Monitoring|January 1, 1988
Development of a radioimmunoassay procedure for sulforidazine and its comparison with a high-performance liquid chromatographic methodB S Chakraborty, E M Hawes, K K MidhaTherapeutic Drug Monitoring|December 1, 1987
Development of a radioimmunoassay procedure for mesoridazine and its comparison with a high-performance liquid chromatographic methodB S Chakraborty, E M Hawes, K K MidhaTherapeutic Drug Monitoring|June 1, 1987
A new radioimmunoassay of thioridazine and its comparison with a high performance liquid chromatographic method and another radioimmunoassayB S Chakraborty, E M Hawes, J Rosenthaler, et al.Pharmaceutical Research|June 1, 1987
Synthesis and properties of haptens for the development of radioimmunoassays for thioridazine, mesoridazine, and sulforidazineB S Chakraborty, M S Sardessai, T J Jaworski, et al.Journal of Pharmaceutical Sciences|June 1, 1989
Comparative bioavailability of a new commercial tablet formulation and two lots of a reference formulation of haloperidolK K Midha, B S Chakraborty, R Schwede, et al.Journal of Pharmaceutical Sciences|January 1, 1990
Comparative bioavailability of two tablet formulations of fluphenazine dihydrochloride in drug-free psychiatric patientsK K Midha, B S Chakraborty, R Schwede, et al.Journal of Pharmaceutical Sciences|March 1, 1990
Bioequivalence of two thorazine tablet formulations using radioimmunoassay and gas chromatographic-mass spectrometric methodsK K Midha, G McKay, B S Chakraborty, et al.Therapeutic Drug Monitoring|September 1, 1987
Therapeutic monitoring of chlorpromazine. IV: Comparison of a new high-performance liquid chromatographic method with radioimmunoassays for parent drug and some of its major metabolitesK K Midha, J W Hubbard, J K Cooper, et al.European Journal of Clinical Pharmacology|January 1, 1989
Interconversion between haloperidol and reduced haloperidol in healthy volunteersB S Chakraborty, J W Hubbard, E M Hawes, et al.Drug Metabolism and Drug Interactions|January 1, 1988
S-oxidation of thioridazine to psychoactive metabolites: an oral dose-proportionality study in healthy volunteersB S Chakraborty, E M Hawes, G McKay, et al.Pageof 2